nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—PDE5A—endothelium—colon cancer	0.0586	0.229	CbGeAlD
Avanafil—PDE5A—blood vessel—colon cancer	0.0541	0.211	CbGeAlD
Avanafil—PDE5A—epithelium—colon cancer	0.0263	0.103	CbGeAlD
Avanafil—PDE5A—smooth muscle tissue—colon cancer	0.0254	0.0989	CbGeAlD
Avanafil—Angina unstable—Capecitabine—colon cancer	0.025	0.0336	CcSEcCtD
Avanafil—PDE5A—renal system—colon cancer	0.0244	0.0952	CbGeAlD
Avanafil—Dyspnoea exertional—Capecitabine—colon cancer	0.0209	0.0281	CcSEcCtD
Avanafil—PDE5A—digestive system—colon cancer	0.02	0.0781	CbGeAlD
Avanafil—Abdominal pain lower—Capecitabine—colon cancer	0.0199	0.0267	CcSEcCtD
Avanafil—PDE5A—vagina—colon cancer	0.0177	0.069	CbGeAlD
Avanafil—Pruritus genital—Capecitabine—colon cancer	0.0151	0.0203	CcSEcCtD
Avanafil—PDE5A—lymph node—colon cancer	0.0114	0.0446	CbGeAlD
Avanafil—Deep vein thrombosis—Capecitabine—colon cancer	0.0104	0.014	CcSEcCtD
Avanafil—Blood bilirubin increased—Irinotecan—colon cancer	0.00998	0.0134	CcSEcCtD
Avanafil—Musculoskeletal pain—Vincristine—colon cancer	0.00981	0.0132	CcSEcCtD
Avanafil—Rhinorrhoea—Capecitabine—colon cancer	0.0078	0.0105	CcSEcCtD
Avanafil—Deep vein thrombosis—Methotrexate—colon cancer	0.00773	0.0104	CcSEcCtD
Avanafil—CYP3A4—renal system—colon cancer	0.00761	0.0297	CbGeAlD
Avanafil—Pain in extremity—Vincristine—colon cancer	0.00704	0.00947	CcSEcCtD
Avanafil—Gastrooesophageal reflux disease—Capecitabine—colon cancer	0.007	0.00941	CcSEcCtD
Avanafil—Oropharyngeal pain—Capecitabine—colon cancer	0.00695	0.00935	CcSEcCtD
Avanafil—Blood bilirubin increased—Capecitabine—colon cancer	0.00668	0.00899	CcSEcCtD
Avanafil—Blood creatinine increased—Irinotecan—colon cancer	0.00642	0.00864	CcSEcCtD
Avanafil—Blood pressure increased—Capecitabine—colon cancer	0.00632	0.0085	CcSEcCtD
Avanafil—CYP3A4—digestive system—colon cancer	0.00624	0.0243	CbGeAlD
Avanafil—Influenza like illness—Capecitabine—colon cancer	0.00614	0.00825	CcSEcCtD
Avanafil—Nasopharyngitis—Fluorouracil—colon cancer	0.00587	0.00789	CcSEcCtD
Avanafil—Angina pectoris—Irinotecan—colon cancer	0.00577	0.00776	CcSEcCtD
Avanafil—Angina pectoris—Fluorouracil—colon cancer	0.00553	0.00743	CcSEcCtD
Avanafil—Upper respiratory tract infection—Irinotecan—colon cancer	0.00551	0.0074	CcSEcCtD
Avanafil—Diabetes mellitus—Capecitabine—colon cancer	0.00527	0.00709	CcSEcCtD
Avanafil—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00527	0.00709	CcSEcCtD
Avanafil—Infestation—Fluorouracil—colon cancer	0.00506	0.0068	CcSEcCtD
Avanafil—Infestation NOS—Fluorouracil—colon cancer	0.00506	0.0068	CcSEcCtD
Avanafil—Hepatic enzyme increased—Methotrexate—colon cancer	0.00497	0.00669	CcSEcCtD
Avanafil—Urinary tract infection—Fluorouracil—colon cancer	0.00492	0.00661	CcSEcCtD
Avanafil—Hot flush—Capecitabine—colon cancer	0.0049	0.0066	CcSEcCtD
Avanafil—Menopausal symptoms—Capecitabine—colon cancer	0.00486	0.00654	CcSEcCtD
Avanafil—Urinary tract disorder—Vincristine—colon cancer	0.00481	0.00647	CcSEcCtD
Avanafil—Connective tissue disorder—Vincristine—colon cancer	0.00478	0.00643	CcSEcCtD
Avanafil—Urethral disorder—Vincristine—colon cancer	0.00477	0.00642	CcSEcCtD
Avanafil—Epistaxis—Fluorouracil—colon cancer	0.00477	0.00642	CcSEcCtD
Avanafil—Sinusitis—Fluorouracil—colon cancer	0.00475	0.00638	CcSEcCtD
Avanafil—Connective tissue disorder—Irinotecan—colon cancer	0.00466	0.00627	CcSEcCtD
Avanafil—CYP3A4—liver—colon cancer	0.00465	0.0181	CbGeAlD
Avanafil—Pain in extremity—Capecitabine—colon cancer	0.00459	0.00617	CcSEcCtD
Avanafil—Cardiac disorder—Vincristine—colon cancer	0.00452	0.00608	CcSEcCtD
Avanafil—Angiopathy—Vincristine—colon cancer	0.00442	0.00594	CcSEcCtD
Avanafil—Flushing—Irinotecan—colon cancer	0.0044	0.00592	CcSEcCtD
Avanafil—Cardiac disorder—Irinotecan—colon cancer	0.0044	0.00592	CcSEcCtD
Avanafil—Mediastinal disorder—Vincristine—colon cancer	0.00439	0.0059	CcSEcCtD
Avanafil—Angiopathy—Irinotecan—colon cancer	0.0043	0.00579	CcSEcCtD
Avanafil—Blood creatinine increased—Capecitabine—colon cancer	0.0043	0.00578	CcSEcCtD
Avanafil—Immune system disorder—Irinotecan—colon cancer	0.00428	0.00576	CcSEcCtD
Avanafil—Mediastinal disorder—Irinotecan—colon cancer	0.00427	0.00575	CcSEcCtD
Avanafil—Mental disorder—Vincristine—colon cancer	0.00427	0.00574	CcSEcCtD
Avanafil—Breast disorder—Capecitabine—colon cancer	0.00415	0.00558	CcSEcCtD
Avanafil—Nasopharyngitis—Capecitabine—colon cancer	0.0041	0.00552	CcSEcCtD
Avanafil—Back pain—Vincristine—colon cancer	0.0041	0.00551	CcSEcCtD
Avanafil—Gastritis—Capecitabine—colon cancer	0.00406	0.00546	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00405	0.00544	CcSEcCtD
Avanafil—Back pain—Irinotecan—colon cancer	0.00399	0.00537	CcSEcCtD
Avanafil—Muscle spasms—Irinotecan—colon cancer	0.00397	0.00534	CcSEcCtD
Avanafil—Influenza—Capecitabine—colon cancer	0.00396	0.00533	CcSEcCtD
Avanafil—Diabetes mellitus—Methotrexate—colon cancer	0.00393	0.00528	CcSEcCtD
Avanafil—Agitation—Vincristine—colon cancer	0.0039	0.00524	CcSEcCtD
Avanafil—Angina pectoris—Capecitabine—colon cancer	0.00386	0.00519	CcSEcCtD
Avanafil—Bronchitis—Capecitabine—colon cancer	0.00381	0.00513	CcSEcCtD
Avanafil—Vertigo—Vincristine—colon cancer	0.00381	0.00512	CcSEcCtD
Avanafil—Abdominal discomfort—Capecitabine—colon cancer	0.0038	0.00511	CcSEcCtD
Avanafil—Vision blurred—Fluorouracil—colon cancer	0.00373	0.00501	CcSEcCtD
Avanafil—Vertigo—Irinotecan—colon cancer	0.00371	0.00499	CcSEcCtD
Avanafil—Upper respiratory tract infection—Capecitabine—colon cancer	0.00368	0.00496	CcSEcCtD
Avanafil—Hypertension—Vincristine—colon cancer	0.00366	0.00492	CcSEcCtD
Avanafil—Myalgia—Vincristine—colon cancer	0.00361	0.00485	CcSEcCtD
Avanafil—Weight increased—Capecitabine—colon cancer	0.00361	0.00485	CcSEcCtD
Avanafil—Cough—Irinotecan—colon cancer	0.0036	0.00484	CcSEcCtD
Avanafil—Hypertension—Irinotecan—colon cancer	0.00356	0.00479	CcSEcCtD
Avanafil—Infestation NOS—Capecitabine—colon cancer	0.00354	0.00475	CcSEcCtD
Avanafil—Infestation—Capecitabine—colon cancer	0.00354	0.00475	CcSEcCtD
Avanafil—Infection—Vincristine—colon cancer	0.00344	0.00462	CcSEcCtD
Avanafil—Urinary tract infection—Capecitabine—colon cancer	0.00344	0.00462	CcSEcCtD
Avanafil—Nervous system disorder—Vincristine—colon cancer	0.00339	0.00456	CcSEcCtD
Avanafil—Haematuria—Capecitabine—colon cancer	0.00337	0.00453	CcSEcCtD
Avanafil—Myalgia—Fluorouracil—colon cancer	0.00337	0.00453	CcSEcCtD
Avanafil—Chest pain—Fluorouracil—colon cancer	0.00337	0.00453	CcSEcCtD
Avanafil—Infection—Irinotecan—colon cancer	0.00335	0.0045	CcSEcCtD
Avanafil—Epistaxis—Capecitabine—colon cancer	0.00333	0.00448	CcSEcCtD
Avanafil—Nervous system disorder—Irinotecan—colon cancer	0.0033	0.00444	CcSEcCtD
Avanafil—Hypotension—Vincristine—colon cancer	0.00323	0.00435	CcSEcCtD
Avanafil—Infection—Fluorouracil—colon cancer	0.00321	0.00431	CcSEcCtD
Avanafil—Nervous system disorder—Fluorouracil—colon cancer	0.00316	0.00426	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Vincristine—colon cancer	0.00315	0.00424	CcSEcCtD
Avanafil—Tachycardia—Fluorouracil—colon cancer	0.00315	0.00423	CcSEcCtD
Avanafil—Hypotension—Irinotecan—colon cancer	0.00315	0.00423	CcSEcCtD
Avanafil—Urinary tract disorder—Capecitabine—colon cancer	0.00313	0.00421	CcSEcCtD
Avanafil—Insomnia—Vincristine—colon cancer	0.00313	0.00421	CcSEcCtD
Avanafil—Oedema peripheral—Capecitabine—colon cancer	0.00313	0.0042	CcSEcCtD
Avanafil—Connective tissue disorder—Capecitabine—colon cancer	0.00312	0.00419	CcSEcCtD
Avanafil—Urethral disorder—Capecitabine—colon cancer	0.00311	0.00418	CcSEcCtD
Avanafil—Breast disorder—Methotrexate—colon cancer	0.00309	0.00415	CcSEcCtD
Avanafil—Insomnia—Irinotecan—colon cancer	0.00305	0.0041	CcSEcCtD
Avanafil—Hypotension—Fluorouracil—colon cancer	0.00301	0.00405	CcSEcCtD
Avanafil—Somnolence—Irinotecan—colon cancer	0.00299	0.00403	CcSEcCtD
Avanafil—Gastrointestinal disorder—Vincristine—colon cancer	0.00299	0.00402	CcSEcCtD
Avanafil—Fatigue—Vincristine—colon cancer	0.00298	0.00401	CcSEcCtD
Avanafil—Eye disorder—Capecitabine—colon cancer	0.00297	0.00399	CcSEcCtD
Avanafil—Dyspepsia—Irinotecan—colon cancer	0.00297	0.00399	CcSEcCtD
Avanafil—Constipation—Vincristine—colon cancer	0.00296	0.00398	CcSEcCtD
Avanafil—Flushing—Capecitabine—colon cancer	0.00295	0.00396	CcSEcCtD
Avanafil—Cardiac disorder—Capecitabine—colon cancer	0.00295	0.00396	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00294	0.00395	CcSEcCtD
Avanafil—Insomnia—Fluorouracil—colon cancer	0.00292	0.00392	CcSEcCtD
Avanafil—Gastrointestinal disorder—Irinotecan—colon cancer	0.00291	0.00391	CcSEcCtD
Avanafil—Fatigue—Irinotecan—colon cancer	0.0029	0.00391	CcSEcCtD
Avanafil—Constipation—Irinotecan—colon cancer	0.00288	0.00387	CcSEcCtD
Avanafil—Angiopathy—Capecitabine—colon cancer	0.00288	0.00387	CcSEcCtD
Avanafil—Somnolence—Fluorouracil—colon cancer	0.00287	0.00386	CcSEcCtD
Avanafil—Immune system disorder—Capecitabine—colon cancer	0.00287	0.00386	CcSEcCtD
Avanafil—Mediastinal disorder—Capecitabine—colon cancer	0.00286	0.00385	CcSEcCtD
Avanafil—Dyspepsia—Fluorouracil—colon cancer	0.00284	0.00382	CcSEcCtD
Avanafil—Abdominal discomfort—Methotrexate—colon cancer	0.00283	0.00381	CcSEcCtD
Avanafil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00279	0.00375	CcSEcCtD
Avanafil—Mental disorder—Capecitabine—colon cancer	0.00278	0.00374	CcSEcCtD
Avanafil—Malnutrition—Capecitabine—colon cancer	0.00276	0.00372	CcSEcCtD
Avanafil—Upper respiratory tract infection—Methotrexate—colon cancer	0.00274	0.00369	CcSEcCtD
Avanafil—Body temperature increased—Vincristine—colon cancer	0.00273	0.00368	CcSEcCtD
Avanafil—Back pain—Capecitabine—colon cancer	0.00267	0.00359	CcSEcCtD
Avanafil—Body temperature increased—Irinotecan—colon cancer	0.00266	0.00358	CcSEcCtD
Avanafil—Muscle spasms—Capecitabine—colon cancer	0.00266	0.00357	CcSEcCtD
Avanafil—Infestation NOS—Methotrexate—colon cancer	0.00263	0.00354	CcSEcCtD
Avanafil—Infestation—Methotrexate—colon cancer	0.00263	0.00354	CcSEcCtD
Avanafil—Vision blurred—Capecitabine—colon cancer	0.0026	0.0035	CcSEcCtD
Avanafil—Body temperature increased—Fluorouracil—colon cancer	0.00255	0.00343	CcSEcCtD
Avanafil—Haematuria—Methotrexate—colon cancer	0.00251	0.00337	CcSEcCtD
Avanafil—Epistaxis—Methotrexate—colon cancer	0.00248	0.00334	CcSEcCtD
Avanafil—Vertigo—Capecitabine—colon cancer	0.00248	0.00334	CcSEcCtD
Avanafil—Asthenia—Vincristine—colon cancer	0.00248	0.00334	CcSEcCtD
Avanafil—Palpitations—Capecitabine—colon cancer	0.00244	0.00328	CcSEcCtD
Avanafil—Asthenia—Irinotecan—colon cancer	0.00242	0.00325	CcSEcCtD
Avanafil—Cough—Capecitabine—colon cancer	0.00241	0.00324	CcSEcCtD
Avanafil—Hypertension—Capecitabine—colon cancer	0.00239	0.00321	CcSEcCtD
Avanafil—Diarrhoea—Vincristine—colon cancer	0.00237	0.00318	CcSEcCtD
Avanafil—Myalgia—Capecitabine—colon cancer	0.00235	0.00316	CcSEcCtD
Avanafil—Arthralgia—Capecitabine—colon cancer	0.00235	0.00316	CcSEcCtD
Avanafil—Chest pain—Capecitabine—colon cancer	0.00235	0.00316	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00234	0.00314	CcSEcCtD
Avanafil—Urinary tract disorder—Methotrexate—colon cancer	0.00233	0.00314	CcSEcCtD
Avanafil—Urethral disorder—Methotrexate—colon cancer	0.00232	0.00311	CcSEcCtD
Avanafil—Diarrhoea—Irinotecan—colon cancer	0.0023	0.0031	CcSEcCtD
Avanafil—Dry mouth—Capecitabine—colon cancer	0.0023	0.00309	CcSEcCtD
Avanafil—Dizziness—Vincristine—colon cancer	0.00229	0.00308	CcSEcCtD
Avanafil—Pruritus—Fluorouracil—colon cancer	0.00228	0.00307	CcSEcCtD
Avanafil—Infection—Capecitabine—colon cancer	0.00224	0.00301	CcSEcCtD
Avanafil—Dizziness—Irinotecan—colon cancer	0.00223	0.003	CcSEcCtD
Avanafil—Nervous system disorder—Capecitabine—colon cancer	0.00221	0.00297	CcSEcCtD
Avanafil—Eye disorder—Methotrexate—colon cancer	0.00221	0.00297	CcSEcCtD
Avanafil—Diarrhoea—Fluorouracil—colon cancer	0.00221	0.00297	CcSEcCtD
Avanafil—Tachycardia—Capecitabine—colon cancer	0.0022	0.00296	CcSEcCtD
Avanafil—Vomiting—Vincristine—colon cancer	0.0022	0.00296	CcSEcCtD
Avanafil—Cardiac disorder—Methotrexate—colon cancer	0.00219	0.00295	CcSEcCtD
Avanafil—Skin disorder—Capecitabine—colon cancer	0.00219	0.00295	CcSEcCtD
Avanafil—Rash—Vincristine—colon cancer	0.00218	0.00293	CcSEcCtD
Avanafil—Dermatitis—Vincristine—colon cancer	0.00218	0.00293	CcSEcCtD
Avanafil—Headache—Vincristine—colon cancer	0.00217	0.00291	CcSEcCtD
Avanafil—Angiopathy—Methotrexate—colon cancer	0.00214	0.00288	CcSEcCtD
Avanafil—Vomiting—Irinotecan—colon cancer	0.00214	0.00288	CcSEcCtD
Avanafil—Immune system disorder—Methotrexate—colon cancer	0.00213	0.00287	CcSEcCtD
Avanafil—Dizziness—Fluorouracil—colon cancer	0.00213	0.00287	CcSEcCtD
Avanafil—Mediastinal disorder—Methotrexate—colon cancer	0.00213	0.00286	CcSEcCtD
Avanafil—Rash—Irinotecan—colon cancer	0.00212	0.00286	CcSEcCtD
Avanafil—Dermatitis—Irinotecan—colon cancer	0.00212	0.00285	CcSEcCtD
Avanafil—Headache—Irinotecan—colon cancer	0.00211	0.00284	CcSEcCtD
Avanafil—Hypotension—Capecitabine—colon cancer	0.00211	0.00283	CcSEcCtD
Avanafil—Mental disorder—Methotrexate—colon cancer	0.00207	0.00278	CcSEcCtD
Avanafil—Malnutrition—Methotrexate—colon cancer	0.00206	0.00277	CcSEcCtD
Avanafil—Nausea—Vincristine—colon cancer	0.00205	0.00276	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00205	0.00276	CcSEcCtD
Avanafil—Vomiting—Fluorouracil—colon cancer	0.00205	0.00276	CcSEcCtD
Avanafil—Insomnia—Capecitabine—colon cancer	0.00204	0.00274	CcSEcCtD
Avanafil—Rash—Fluorouracil—colon cancer	0.00203	0.00274	CcSEcCtD
Avanafil—Dermatitis—Fluorouracil—colon cancer	0.00203	0.00273	CcSEcCtD
Avanafil—Headache—Fluorouracil—colon cancer	0.00202	0.00272	CcSEcCtD
Avanafil—Nausea—Irinotecan—colon cancer	0.002	0.00269	CcSEcCtD
Avanafil—Back pain—Methotrexate—colon cancer	0.00199	0.00268	CcSEcCtD
Avanafil—Dyspepsia—Capecitabine—colon cancer	0.00198	0.00267	CcSEcCtD
Avanafil—Gastrointestinal disorder—Capecitabine—colon cancer	0.00195	0.00262	CcSEcCtD
Avanafil—Fatigue—Capecitabine—colon cancer	0.00194	0.00261	CcSEcCtD
Avanafil—Vision blurred—Methotrexate—colon cancer	0.00194	0.00261	CcSEcCtD
Avanafil—Constipation—Capecitabine—colon cancer	0.00193	0.00259	CcSEcCtD
Avanafil—Nausea—Fluorouracil—colon cancer	0.00192	0.00258	CcSEcCtD
Avanafil—Vertigo—Methotrexate—colon cancer	0.00185	0.00248	CcSEcCtD
Avanafil—Cough—Methotrexate—colon cancer	0.00179	0.00241	CcSEcCtD
Avanafil—Body temperature increased—Capecitabine—colon cancer	0.00178	0.0024	CcSEcCtD
Avanafil—Arthralgia—Methotrexate—colon cancer	0.00175	0.00235	CcSEcCtD
Avanafil—Myalgia—Methotrexate—colon cancer	0.00175	0.00235	CcSEcCtD
Avanafil—Chest pain—Methotrexate—colon cancer	0.00175	0.00235	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00174	0.00234	CcSEcCtD
Avanafil—Infection—Methotrexate—colon cancer	0.00167	0.00224	CcSEcCtD
Avanafil—Nervous system disorder—Methotrexate—colon cancer	0.00165	0.00221	CcSEcCtD
Avanafil—Skin disorder—Methotrexate—colon cancer	0.00163	0.00219	CcSEcCtD
Avanafil—Asthenia—Capecitabine—colon cancer	0.00162	0.00218	CcSEcCtD
Avanafil—Pruritus—Capecitabine—colon cancer	0.0016	0.00215	CcSEcCtD
Avanafil—Hypotension—Methotrexate—colon cancer	0.00157	0.00211	CcSEcCtD
Avanafil—Diarrhoea—Capecitabine—colon cancer	0.00154	0.00207	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00153	0.00206	CcSEcCtD
Avanafil—Insomnia—Methotrexate—colon cancer	0.00152	0.00204	CcSEcCtD
Avanafil—Somnolence—Methotrexate—colon cancer	0.00149	0.00201	CcSEcCtD
Avanafil—Dizziness—Capecitabine—colon cancer	0.00149	0.00201	CcSEcCtD
Avanafil—Dyspepsia—Methotrexate—colon cancer	0.00148	0.00199	CcSEcCtD
Avanafil—Gastrointestinal disorder—Methotrexate—colon cancer	0.00145	0.00195	CcSEcCtD
Avanafil—Fatigue—Methotrexate—colon cancer	0.00145	0.00195	CcSEcCtD
Avanafil—Vomiting—Capecitabine—colon cancer	0.00143	0.00193	CcSEcCtD
Avanafil—Rash—Capecitabine—colon cancer	0.00142	0.00191	CcSEcCtD
Avanafil—Dermatitis—Capecitabine—colon cancer	0.00142	0.00191	CcSEcCtD
Avanafil—Headache—Capecitabine—colon cancer	0.00141	0.0019	CcSEcCtD
Avanafil—Nausea—Capecitabine—colon cancer	0.00134	0.0018	CcSEcCtD
Avanafil—Body temperature increased—Methotrexate—colon cancer	0.00133	0.00178	CcSEcCtD
Avanafil—Asthenia—Methotrexate—colon cancer	0.0012	0.00162	CcSEcCtD
Avanafil—Pruritus—Methotrexate—colon cancer	0.00119	0.0016	CcSEcCtD
Avanafil—Diarrhoea—Methotrexate—colon cancer	0.00115	0.00154	CcSEcCtD
Avanafil—Dizziness—Methotrexate—colon cancer	0.00111	0.00149	CcSEcCtD
Avanafil—Vomiting—Methotrexate—colon cancer	0.00107	0.00144	CcSEcCtD
Avanafil—Rash—Methotrexate—colon cancer	0.00106	0.00142	CcSEcCtD
Avanafil—Dermatitis—Methotrexate—colon cancer	0.00106	0.00142	CcSEcCtD
Avanafil—Headache—Methotrexate—colon cancer	0.00105	0.00141	CcSEcCtD
Avanafil—Nausea—Methotrexate—colon cancer	0.000997	0.00134	CcSEcCtD
